55.42MMarket Cap-1988P/E (TTM)
2.140High2.062Low5.47KVolume2.100Open2.110Pre Close11.55KTurnover0.05%Turnover RatioLossP/E (Static)26.29MShares6.47052wk High1.09P/B25.48MFloat Cap1.13152wk Low--Dividend TTM12.09MShs Float17.200Historical High--Div YieldTTM3.72%Amplitude1.131Historical Low2.109Avg Price1Lot Size
LAVA Therapeutics Stock Forum
LAVA Therapeutics N.V., a leader in the biotechnology sector, has recently announced a significant clinical development milestone achieved by Pfizer for the drug PF-08046052. This milestone has prompted the first payment of $7 million to LAVA, marking a notable event in the field of immuno-oncology. $LAVA Therapeutics(LVTX.US)$
https://stockregion.app/p/biotech-leader-announces-7m-milestone
No comment yet